Literature DB >> 10574329

Homologous and heterologous phosphorylation of the vasopressin V1a receptor.

N Ancellin1, L Preisser, S Le Maout, M Barbado, C Créminon, B Corman, A Morel.   

Abstract

The vasopressin V1a receptor undergoes homologous and heterologous desensitizations which can be mimicked by activation of protein kinase C. This suggests that phosphorylation of the V1a receptor may be involved in the desensitization mechanisms. Such a phosphorylation was presently investigated in HEK 293 cells stably transfected with rat vasopressin V1a receptor. Metabolic labelling and immunoprecipitation of epitope-tagged V1a receptor evidenced a 52-kDa band and a 92-kDa band. Glycosidase treatments and immunoblotting experiments suggest that the 52-kDa band corresponds to an immature unprocessed receptor protein, whereas the 92-kDa band would correspond to a highly glycosylated form of the mature V1a receptor. Exposure of the cells to vasopressin induced a selective 32P phosphate incorporation in the 92-kDa form of the receptor. This homologous ligand-induced phosphorylation was dose dependent with maximal phosphate incorporation corresponding to four times the basal level. Stimulation of the endogenous phospholipase C-coupled m3 muscarinic receptor by carbachol-induced heterologous phosphorylation of the V1a receptor whose amplitude was half that of the homologous phosphorylation. This heterologous phosphorylation was associated with a reduced vasopressin-dependent increase in intracellular calcium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574329     DOI: 10.1016/s0898-6568(99)00035-2

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?

Authors:  Marilyn A Davies; Beth Ann Compton-Toth; Sandra J Hufeisen; Herbert Y Meltzer; Bryan L Roth
Journal:  Psychopharmacology (Berl)       Date:  2004-10-13       Impact factor: 4.530

2.  Endogenously expressed muscarinic receptors in HEK293 cells augment up-regulation of stably expressed α4β2 nicotinic receptors.

Authors:  Gregory P Hussmann; Robert P Yasuda; Yingxian Xiao; Barry B Wolfe; Kenneth J Kellar
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

3.  Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz.

Authors:  Dhwanil A Dalwadi; Seongcheol Kim; Shahnawaz M Amdani; Zhenglan Chen; Ren-Qi Huang; John A Schetz
Journal:  Pharmacol Res       Date:  2016-05-06       Impact factor: 7.658

4.  Full and partial agonists of muscarinic M3 receptors reveal single and oscillatory Ca2+ responses by beta 2-adrenoceptors.

Authors:  Nisha Kurian; Caroline J Hall; Graeme F Wilkinson; Michael Sullivan; Andrew B Tobin; Gary B Willars
Journal:  J Pharmacol Exp Ther       Date:  2009-05-06       Impact factor: 4.030

5.  Desensitisation of native and recombinant human urotensin-II receptors.

Authors:  Madura S Batuwangala; Girolamo Calo; Remo Guerrini; Leong L Ng; John McDonald; David G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-08-13       Impact factor: 3.000

6.  Occipital Artery Function during the Development of 2-Kidney, 1-Clip Hypertension in Rats.

Authors:  Stephen P Chelko; Chad W Schmiedt; Tristan H Lewis; Tom P Robertson; Stephen J Lewis
Journal:  Int J Vasc Med       Date:  2014-07-22

7.  Nanoluciferase Reporter Gene System Directed by Tandemly Repeated Pseudo-Palindromic NFAT-Response Elements Facilitates Analysis of Biological Endpoint Effects of Cellular Ca2+ Mobilization.

Authors:  Wei Zhang; Terunao Takahara; Takuya Achiha; Hideki Shibata; Masatoshi Maki
Journal:  Int J Mol Sci       Date:  2018-02-18       Impact factor: 5.923

8.  GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons.

Authors:  N Benamer; F Marti; R Lujan; R Hepp; T G Aubier; A A M Dupin; G Frébourg; S Pons; U Maskos; P Faure; Y A Hay; B Lambolez; L Tricoire
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

Review 9.  The Biology of Vasopressin.

Authors:  Samantha Sparapani; Cassandra Millet-Boureima; Joshua Oliver; Kathy Mu; Pegah Hadavi; Tamar Kalostian; Nazifa Ali; Carla Maria Avelar; Marion Bardies; Brenton Barrow; Minky Benedikt; Giuliana Biancardi; Raminder Bindra; Lisa Bui; Zakaria Chihab; Ashley Cossitt; Jeffrey Costa; Tina Daigneault; Jocelyn Dault; Isa Davidson; Jonathan Dias; Emie Dufour; Sabine El-Khoury; Nargess Farhangdoost; Anika Forget; Alexa Fox; Myriam Gebrael; Maria Concetta Gentile; Olivia Geraci; Ansley Gnanapragasam; Elias Gomah; Elie Haber; Claudia Hamel; Thivya Iyanker; Christina Kalantzis; Sara Kamali; Elsa Kassardjian; Hryssi Krissy Kontos; Thi Bich Uyen Le; Daniella LoScerbo; Yan Fang Low; Danielle Mac Rae; Flore Maurer; Sana Mazhar; Alice Nguyen; Kathy Nguyen-Duong; Chelsea Osborne-Laroche; Hwi Wun Park; Emilie Parolin; Kahlila Paul-Cole; Leah Sarah Peer; Margaux Philippon; Charles-Alexandre Plaisir; Jessica Porras Marroquin; Simran Prasad; Rewaparsad Ramsarun; Saad Razzaq; Samantha Rhainds; Damien Robin; Ryan Scartozzi; Davindra Singh; Sajad Soleimani Fard; Maxim Soroko; Nastaran Soroori Motlagh; Kiri Stern; Laila Toro; M Wyatt Toure; Stephanie Tran-Huynh; Sarah Trépanier-Chicoine; Claudia Waddingham; Aaliyah Jasmine Weekes; Allison Wisniewski; Chiara Gamberi
Journal:  Biomedicines       Date:  2021-01-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.